In a large-scale (N = 1487) general population online study, we investigated the relationship between past experience with classic psychedelic substances (e.g. LSD, psilocybin, mescaline), nature relatedness, and ecological behavior (e.g. saving water, recycling). Using structural equation modeling we found that experience with classic psychedelics uniquely predicted self-reported engagement in pro-environmental behaviors, and that this relationship was statistically explained by people’s degree of self-identification with nature. Our model controlled for experiences with other classes of psychoactive substances (cannabis, dissociatives, empathogens, popular legal drugs) as well as common personality traits that usually predict drug consumption and/or nature relatedness (openness to experience, conscientiousness, conservatism). Although correlational in nature, results suggest that lifetime experience with psychedelics in particular may indeed contribute to people’s pro-environmental behavior by changing their self-construal in terms of an incorporation of the natural world, regardless of core personality traits or general propensity to consume mind-altering substances. Thereby, the present research adds to the contemporary literature on the beneficial effects of psychedelic substance use on mental wellbeing, hinting at a novel area for future research investigating their potentially positive effects on a societal level. Limitations of the present research and future directions are discussed.
AronAAronENTudorM. (1991) Close relationships as including other in the self. J Pers Soc Psychol60: 241–253.
2.
AtranSMedinDRossN. (2002) Folkecology, cultural epidemiology, and the spirit of the commons: A garden experiment in the Maya lowlands, 1991–2001. Curr Anthropol43: 421–450.
3.
BachmanJGO’MalleyPMJohnstonLD (1980) Correlates of Drug Use, Part I: Selected Measures of Background, Recent Experiences, and Life-style Orientations. Ann Arbor, MI: Institute for Social Research.
4.
BallSA (2005) Personality traits, problems, and disorders: Clinical applications to substance use disorders. J Res Pers39: 84–102.
5.
BerenguerJ (2007) The effect of empathy in proenvironmental attitudes and behaviors. Environ Behav39: 269–283.
6.
BogenschutzMPPommyJM (2012) Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: From indirect evidence to testable hypotheses. Drug Test Anal4: 7–8.
7.
BoggTRobertsBW (2004) Conscientiousness and health-related behaviors: A meta-analysis of the leading behavioral contributors to mortality. Psychol Bull130: 887–919.
8.
BoumbaVAMitselouAVougiouklakisT (2004) Fatal poisoning from ingestion of Datura stramonium seeds. Vet Hum Toxicol46: 81–82.
9.
BrownTK (2013) Ibogaine in the treatment of substance dependence. Curr Drug Abuse Rev6: 3–16.
BoyntonMHRichmanLS (2014) An online daily diary study of alcohol use using Amazon’s Mechanical Turk. Drug Alcohol Rev33: 456–461.
12.
BuhrmesterMKwangTGoslingSD (2011) Amazon’s Mechanical Turk a new source of inexpensive, yet high-quality, data?Perspect Psychol Sci6: 3–5.
13.
CapaldiCADopkoRLZelenskiJM (2014) The relationship between nature connectedness and happiness: A meta-analysis. Front Psychol5: 976.
14.
CarbonaroTMBradstreetMPBarrettFS. (2016) Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol30: 1268–1278.
15.
Carhart-HarrisRLBolstridgeMRuckerJ. (2016) Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. Lancet Psychiatry3: 619–627.
16.
Carhart-HarrisRLErritzoeDWilliamsT. (2012a) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci USA109: 2138–2143.
17.
Carhart-HarrisRLLeechRWilliamsTM. (2012b) Implications for psychedelic-assisted psychotherapy: Functional magnetic resonance imaging study with psilocybin. Br J Psychiatry200: 238–244.
18.
Carhart-HarrisRLKaelenMWhalleyMG. (2015) LSD enhances suggestibility in healthy volunteers. Psychopharmacology232: 785–794.
19.
Center for Behavioral Health Statistics and Quality (2015) Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf (accessed 20 October 2016).
20.
CorazzaOSchifanoFSimonatoP. (2012) Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine. Hum Psychopharm Clin27: 145–149.
21.
CourtwrightDT (2001) Forces of Habit: Drugs and the Making of the Modern World. Cambridge, MA: Harvard University Press.
22.
CurranHVMorganC (2000) Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction95: 575–590.
23.
DEFRA (2008) A Framework for Pro-environmental Behaviours. London, UK: Department for Environment, Food and Rural Affairs.
24.
DumontGJSweepFCvan der StehenR. (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci4: 359–366.
FeinbergMWillerR (2013) The moral roots of environmental attitudes. Psychol Sci24: 56–62.
27.
GalinskyADKuGWangCS (2005) Perspective-taking and self-other overlap: Fostering social bonds and facilitating social coordination. Group Process Intergroup Relat8: 109–124.
28.
GasserPHolsteinDMichelY. (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis202: 513–520.
29.
GebhardUNeversPBillmann-MahechaE (2003) Moralizing trees: Anthropomorphism and identity in children’s relationships to nature. In: ClaytonS (ed.) Identity and the Natural Environment: The Psychological Significance of Nature. Cambridge, UK: MIT Press, pp. 45–66.
30.
GoodmanJKCryderCECheemaA (2013) Data collection in a flat world: The strengths and weaknesses of Mechanical Turk samples. J Behav Decis Mak26: 213–224.
31.
GoslingSDRentfrowPJSwannWBJr (2003) A very brief measure of the Big-Five personlity domains. J Res Pers37: 504–528.
32.
GrayKYoungLWaytzA (2012) Mind perception is the essence of morality. Psychol Inq23: 101–124.
33.
GriffithsRRRichardsWJohnsonM. (2008) Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J Psychopharmacol22: 621–632.
GriffithsRRRichardsWAMcCannU. (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology187: 268–283.
36.
HendricksPSThorneCBClarkCB. (2015) Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. J Psychopharmacol29: 280–288.
37.
HollisterL (1984) Effects of hallucinogens in humans. In: JacobsB (ed.) Hallucinogens: Neurochemical, Behavioral and Clinical Perspectives. New York, NY: Raven Press, pp. 203–226.
38.
HussongAM (2000) The settings of adolescent alcohol and drug use. J Youth Adolesc29: 107–119.
39.
IPCC (2014) Climate Change 2014: Synthesis Report. Contribution of Working Groups I, II and III to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change. Geneva, Switzerland: IPCC.
40.
JohansenP-ØKrebsTS (2015) Psychedelics not linked to mental health problems or suicidal behavior: A population study. J Psychopharmacol29: 270–279.
41.
JohnsonMRichardsWGriffithsR (2008) Human hallucinogen research: Guidelines for safety. J Psychopharmacol22: 603–620.
42.
KellertSRWilsonEO (1995) The Biophilia Hypothesis. Washington, DC: Island Press.
43.
KesebirSKesebirP (2017) A growing disconnection from nature is evident in cultural products. Perspect Psychol Sci12: 258–269.
44.
KjellgrenAErikssonANorlanderT (2009) Experiences of encounters with ayahuasca-“the vine of the soul”. J Psychoactive Drugs41: 309–315.
45.
KrebsTJohansenP-Ø (2012) Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. J Psychopharmacol26: 994–1002.
46.
KrumpalI (2013) Determinants of social desirability bias in sensitive surveys: A literature review. Qual Quant47: 2025–2047.
47.
KurzbanRDukesAWeedenJ (2010) Sex, drugs and moral goals: Reproductive strategies and views about recreational drugs. Proc R Soc Lond B Biol Sci277: 3501–3508.
48.
LittleTDCunninghamWAShaharG. (2002) To parcel or not to parcel: Exploring the question, weighing the merits. Struct Equ Modeling9: 151–173.
49.
LukeD (2011) Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology and ontology. J Soc Psych Res75: 26–42.
50.
LunaLE (1984) The healing practices of a Peruvian shaman. J Ethnopharmacol11: 123–133.
51.
MabryEAKhavariKA (1986) Attitude and personality correlates of hallucinogenic drug use. Int J Addict21: 691–699.
52.
MacLeanKAJohnsonMWGriffithsRR (2011) Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol25: 1453–1461.
53.
MallerCTownsendMPryorA. (2006) Healthy nature healthy people: ‘Contact with nature’ as an upstream health promotion intervention for populations. Health Promot21: 44–54.
54.
MastersRHoustonJ (1966) The Varieties of Psychedelic Experience. New York, NY: Rinehart and Winston.
55.
MithoeferMCWagnerMTMithoeferAT. (2011) The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. J Psychopharmacol25: 439–452.
56.
MoffatBMJohnsonJLShovellerJA (2009) A gateway to nature: Teenagers’ narratives on smoking marijuana outdoors. J Environ Psychol29: 86–94.
57.
NicholsDE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. J Psychoactive Drugs18: 305–313.
NisbetEKZelenskiJMMurphySA (2009) The Nature Relatedness Scale: Linking individuals’ connection with nature to environmental concern and behavior. Environ Behav41: 715–740.
60.
NuttDJKingLANicholsDE (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Rev Neurosci14: 577–585.
61.
OriansGHHeerwagenJH (1992) Evolved responses to landscapes. In: BarkowJHCosmidesL (eds) Adapted Mind: Evolutionary Psychology and the Generation of Culture. New York, NY: Oxford University Press, pp. 555–579.
62.
PaiAHeiningM (2007) Ketamine. Contin Educ Anaesth Crit Care Pain7: 59–63.
63.
PaolacciGChandlerJ (2014) Inside the Turk: Understanding Mechanical Turk as a participant pool. Curr Dir Psychol Sci23: 184–188.
R Core Team (2015) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
66.
RandDGPeysakhovichAKraft-ToddGT. (2014) Social heuristics shape intuitive cooperation. Nat Commun5: 3677.
67.
RedmilesEMKrossSPradhanA. (2017) How Well Do My Results Generalize? Comparing Security and Privacy Survey Results from MTurk and Web Panels to the US. Retrieved from http://drum.lib.umd.edu/handle/1903/19164 (accessed 13 March 2017).
68.
RosseelY (2012) Lavaan: An R package for structural equation modeling. J Stat Softw48: 1–36.
69.
RoszakTEGomesMEKannerAD (1995) Ecopsychology: Restoring the Earth Healing the Mind. Sierra Club Books. San Francisco, CA: Sierra Club Books.
70.
RudgleyR (1995) The archaic use of hallucinogens in Europe: An archaeology of altered states. Addiction90: 163–164.
71.
SchultzPWStoneWF (1994). Authoritarianism and attitudes toward the environment. Environ Behav26: 25–37.
72.
SessaBJohnsonMW (2015) Can psychedelic compounds play a part in drug dependence therapy?Br J Psychiatry206: 1–3.
73.
SessaB (2016) MDMA and PTSD treatment: “PTSD: From novel pathophysiology to innovative therapeutics”. Neurosci Lett649: 176–180.
74.
ShanonB (2002) The Antipodes of the Mind. New York: Oxford University Press.
75.
ShapiroDNChandlerJMuellerPA (2013) Using Mechanical Turk to study clinical populations. Clin Psychol Sci1: 213–220.
SmithC (1958) A new adjunct to the treatment of alcoholism: The hallucinogenic drugs. Q J Stud Alcohol19: 406–417.
78.
SpethJSpethCKaelenM. (2016) Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. J Psychopharmacol30: 344–353.
79.
StrassmanRWojtowiczSLunaLE. (2008) Inner Paths to Outer Space: Journeys to Alien Worlds Through Psychedelics and Other Spiritual Technologies. Rochester, VT: Park Street Press.
80.
SwendsenJDConwayKPRounsavilleBJ. (2002) Are personality traits familial risk factors for substance use disorders? Results of a controlled family study. Am J Psychiatry159: 1760–1766.
81.
TagliazucchiERosemanLKaelenM. (2016) Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr Biol26: 1043–1050.
82.
TamKPLeeSLChaoMM (2013) Saving Mr. Nature: Anthropomorphism enhances connectedness to and protectiveness toward nature. J Exp Soc Psychol49: 514–521.
83.
Van Den BoschMADepledgeMH (2015) Healthy people with nature in mind. BMC Public Health15: 1–7.
84.
VollenweiderFXGammaALiechtiM. (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology19: 241–251.
85.
VollenweiderFXKometerM (2010) The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nat Rev Neurosci11: 642–651.
86.
WaytzACacioppoJEpleyN (2010) Who sees human?Perspect Psychol Sci5: 219–232.
87.
WhitmarshLO’NeillS (2010) Green identity, green living? The role of pro-Environmental self-identity in determining consistency across diverse pro-environmental behaviours. J Environ Psychol30: 305–314.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
